Abstract
INTRODUCTION
In March 2018, The UK Biobank released an updated version of the genetic 120 information (including directly genotyped genotypes and imputed genotypes) of 121 501,708 samples to all approved researchers. The detailed QC steps of imputation 122 were described by Bycroft et al. 27 
123

Definitions of pain phenotypes 124
We used a specific pain-related questionnaire adapted by the UK Biobank, which 125 
6159) 131
For each pain phenotype, cases were defined as those who selected the specific 132 pain site option for the above question, regardless of whether they had selected 133 other options. For example, headache cases are those who selected the 'Headache' 134 option; Facial pain cases are those who selected the 'Facial pain' option; etc. 135
For each GWAS analysis, controls were those who selected the 'None of the above' 136 option. Thus we used the same 'no pain' control population for all pain phenotypes in 137 different body sites. 138
Definitions of depression and neuroticism 139
The phenotypes of depression and neuroticism were defined by the psychological 140 cohorts collected by the LD hub. [28] [29] [30] [31] The original researchers of these cohorts 141 agreed to share the GWAS summary statistics on depression and neuroticism with7 the LD hub for generating genetic correlations. Therefore, we selected the 143 'Psychiatric diseases' option and the 'Personality traits' option in the LD hub to 144 include the depression and neuroticism traits. These traits are: Depressive 145 symptoms, 28 Neuroticism (x 2 studies), [29] [30] Major depressive disorder. 31 However, for 146 neuroticism, we only chose the version used by Okbay et al, 30 as it is a GWAS meta-147 analysis publication, the results of which included the results from van den Berg et 148 al. 29 
149
Statistical analysis 150
Generating the heritabilities of all pain phenotypes 151
In this study, genome-wide complex trait analysis (GCTA) was used to calculate 152 narrow-sense SNP-based heritabilities based on the genomic-relatedness-based 153 restricted maximum-likelihood (GREML) approach. 32 
154
Generating GWAS summary statistics of all pain phenotypes 155
In this study, genotype data were analysed in BGENIE (https://jmarchini.org/bgenie/), 156 as recommended by UK Biobank. Routine QC steps included: removing SNPs with 157 INFO scores less than 0.1, SNPs with minor allele frequency less than 0.5%, or 158
SNPs that failed Hardy-Weinberg tests P < 10 -6
. SNPs on the X and Y chromosomes 159 and mitochondrial SNPs were also removed. We further removed those whose 160 ancestry was not white British based on principal component analysis, those who 161 were related at least another participant in the cohort (a cut-off value of 0.025 in the 162 generation of the genetic relationship matrix) and those who failed QC. Association 163 tests based on standard Frequentist association were performed using BGENIE 164 adjusting for age, sex, body mass index (BMI), 9 population principal components, 
Genetic correlations between pain and depression and neuroticism 200
Through the genetic correlation analysis, we identified multiple significant and 201 positive correlations between pain phenotypes and depression and neuroticism. 202 and all were statistically significant after adjustment for multiple testing. 
Genetic correlations among pain phenotypes 231
Through the LDSC software, we identified multiple significant and positive 232 correlations among pain phenotypes (Table 3) 
The nature of the relationship between pain phenotypes and depression has been 250 uncertain. Epidemiological studies have identified that depression is reported more 251 often by patients reporting pain and also that pain is a risk factor for the future 252 development of depression. 33 Patients with psychosomatic conditions suffer from 253 psychiatric disorders (such as depression) and physical diseases (such as bodily 254 pain), and their co-occurrence is associated with greater disability than either 255 condition alone. 34 Although the exact mechanisms linking these conditions are not 256 clear, genetic mechanisms are implied through shared biological pathways, such as 257 gene expression in biological networks, the endocannabinoid system, the 258 hypothalamic-pituitary-adrenal axis and inflammatory pathways. 35 Our study 259 correlations between hip pain and knee pain and depression were contrary to 266 previous observations that depression and knee pain or hip pain are strongly 267 related. 36 Previous studies have shown that knee pain from osteoarthritis increases a 268 person's risk of developing subsequent depression. 37 A systematic review of the 269 relationship between knee pain and multiple psychiatric traits also found an 270 association between depression and knee pain. 38 While genetic factors may 271 contribute to the pain at different sites, our findings suggest that non-genetic factors 272 may be more important in the co-occurrence of knee or hip pain with depression. 273
The genetic relationships between pain phenotypes and neuroticism are also of 274 interest and are similar to those between pain and depression. Neuroticism was 275 identified to be a potential risk factor for elevated pain responses in laboratory pain in 276 healthy children, and can likely exacerbate pain responses when coupled with fear of 277 bodily sensations. 39 Neuroticism has also been independently associated with 278 greater pain catastrophizing and pain-related anxiety. 40 Our genetic correlation 279 results were consistent with findings from epidemiological studies of headache, 41 280 neck or shoulder pain, 42 back pain, 43 and pain all over the body. 44 No previous 281 studies have shown epidemiological data for the relationships between neuroticism 282 and facial pain or stomach or abdominal pain. It was also suggested from our study 283 that there were no significant genetic relationships between knee pain or hip pain 284 and neuroticism. To our knowledge, no previous studies have specifically examined 285 the epidemiological relationships between neuroticism and hip pain or knee pain. 286
Our findings suggest that hip pain and knee pain may belong to a separate pain 287 group and should be considered separately when designing studies of the genetic 288 relationships between pain and psychiatric disorders.
3
A significant and positive correlation between a pain phenotype and a psychiatric 290 trait reflects share genetic architecture. This can reflect pleiotropy, where specific 291 genetic alleles give risk to both phenotypes, but it can also reflect mediated 292 pleiotropy where there is a directional or causal association between these traits. 20 It 293 is also possible for positive genetic correlations to be generated by misclassification 294 of pain as depression, or major depression as pain. 45 Whilst this seems unlikely to 295 explain the convergent genetic correlation of neuroticism with pain, it will be 296 important to examine whether there is subgroup heterogeneity amongst individuals 297 with pain on depression that can be explained by variation on the other trait. The highest narrow-sense heritability among all pain phenotypes in this study was 309 0.31 for pain all over the body. The heritablities of all other pain phenotypes were 310 moderate. The narrow-sense heritability does not take gene-gene interactions, gene-311 environment interactions, or the contribution from rare variants into account, and is 312 therefore likely to be an under estimate of the true heritability. This is the first report 313 of the heritabilities for facial pain (h1 4 the best of our knowledge, and suggests important genetic contributions to chronic 315 pain at all body sites. 316
Arguably the greatest strength of the current study was the large size of the UK 317
Biobank sample. This provided the largest single sample size for many of the pain 318 phenotypes studied here compared with previous GWAS studies of pain.
319
Nevertheless, potential limitations should also be taken into account. The 320 phenotyping in UK Biobank was based on a single specific non-standard pain-related 321 question. This means that all pain phenotypes were broadly-defined and unfiltered 322 by other potentially relevant information on the nature, duration or intensity of the 323 pain. Similar limitations also apply to the psychological traits measured in UK 324
Biobank and elsewhere. 46 In future, new pain questionnaires may be administered to 325 participants in UK Biobank, and this will allow for more detailed and focused 326 phenotyping for use in future analyses. 
492
Please note, the genetic correlations between these traits and hip pain and knee pain 493 were not significant (P > 0.002, Table 2 ). 
